First detection of coherent elastic neutrino-nucleus scattering on germanium

Autor: Adamski, S., Ahn, M., Barbeau, P. S., Belov, V., Bernardi, I., Bock, C., Bolozdynya, A., Bouabid, R., Browning, J., Cabrera-Palmer, B., Cedarblade-Jones, N., Rivera, J. Colón, Conley, E., da Silva, V., Daughhetee, J., Detwiler, J., Ding, K., Durand, M. R., Efremenko, Y., Elliott, S. R., Erlandson, A., Fabris, L., Galindo-Uribarri, A., Green, M. P., Hakenmüller, J., Heath, M. R., Hedges, S., Jeong, H., Johnson, B. A., Johnson, T., Jones, H., Khromov, A., Konovalov, A., Kozlova, E., Kumpan, A., Kyzylova, O., Lee, Y., Li, G., Li, L., Link, J. M., Liu, J., Luxnat, M., Major, A., Mann, K., Markoff, D. M., Mattingly, J., Moye, J., Mueller, P. E., Newby, J., Ogoi, N., O'Reilly, J., Parno, D. S., Pérez-Loureiro, D., Pershey, D., Prior, C. G., Queen, J., Rapp, R., Ray, H., Razuvaeva, O., Reyna, D., Rich, G. C., Rudik, D., Runge, J., Salvat, D. J., Sander, J., Scholberg, K., Shakirov, A., Simakov, G., Snow, W. M., Sosnovtsev, V., Stringer, M., Subedi, T., Suh, B., Sur, B., Tayloe, R., Tellez-Giron-Flores, K., Tsai, Y. -T., van Nieuwenhuizen, E. E., Virtue, C. J., Visser, G., Walkup, K., Ward, E. M., Wongjirad, T., Yang, Y., Yoo, J., Yu, C. -H., Zaalishvili, A.

We report the first detection of coherent elastic neutrino-nucleus scattering (CEvNS) on germanium, measured at the Spallation Neutron Source at Oak Ridge National Laboratory. The Ge-Mini detector of the COHERENT collaboration employs large-mass, low

Externí odkaz: http://arxiv.org/abs/2406.13806

Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study

Autor: Lu, S., Ahn, M.-J., Reungwetwattana, T., Özgüroğlu, M., Kato, T., Yang, J.C.-H., Huang, M., Fujiki, F., Inoue, T., Quang, L.-V., Sriuranpong, V., Vicente, D., Fuentes, C., Chaudhry, A.A., Poole, L., Armenteros Monterroso, E., Rukazenkov, Y., van der Gronde, T., Ramalingam, S.S.

Publikováno v: In Annals of Oncology

Pembrolizumab versus methotrexate, docetaxel, or cetuximab in recurrent or metastatic head and neck squamous cell carcinoma (KEYNOTE-040): Subgroup analysis by pattern of disease recurrence

Autor: Harrington, K.J., Cohen, E.E.W., Soulières, D., Dinis, J., Licitra, L., Ahn, M.-J., Soria, A., Machiels, J.-P., Mach, N., Mehra, R., Burtness, B., Swaby, R.F., Lin, J., Ge, J., Lerman, N., Tourneau, C. Le

Publikováno v: In Oral Oncology December 2023 147

A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancer

Autor: Galffy, G., Lugowska, I., Poddubskaya, E.V., Cho, B.C., Ahn, M.-J., Han, J.-Y., Su, W.-C., Hauke, R.J., Dyar, S.H., Lee, D.H., Serwatowski, P., Estelles, D.L., Holden, V.R., Kim, Y.J., Vladimirov, V., Horvath, Z., Ghose, A., Goldman, A., di Pietro, A., Wang, J., Murphy, D.A., Alhadab, A., Laskov, M.

Publikováno v: In ESMO Open June 2023 8(3)

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

Autor: Paz-Ares, L., Barlesi, F., Siena, S., Ahn, M.-J., Drilon, A., Conley, A., Rolfo, C., Wolf, J., Seto, T., Doebele, R., Kapre, A., Chen, D., McCallum, S., Osborne, S., Demetri, G.

Publikováno v: In ESMO Open June 2021 6(3)